Cetaphil AI Market Strategy Report - Sunscreen Brands

Answer Capsule

Cetaphil is visible in AI-generated sunscreen recommendations but is losing recommendation power at the point where buyers form shortlists. In September 2026, Cetaphil appeared in 26.05% of qualified AI observations but received a valid recommendation in only 20.11%, and it was never the first recommended option in any observation. The brand's clearest weakness is a two-month decline in valid recommendation coverage, down 11.9 percentage points from July 2026, the sharpest retreat in the tracked category. Its clearest opportunity is converting its remaining brand presence into shortlist placement, since the gap between raw mention presence and valid recommendation coverage shows that AI systems still surface Cetaphil but increasingly route the recommendation to other brands.

Who This Report Is For

This report is written for Cetaphil brand leaders, category marketers, and ecommerce and retail strategy teams evaluating how AI and search surfaces present the brand during sunscreen discovery and consideration.

Report Card

Executive Summary

Cetaphil holds meaningful presence in AI-generated sunscreen answers but weak recommendation conversion. The September 2026 benchmark recorded 136 mentions of Cetaphil across 522 qualified observations, a raw mention presence rate of 26.05%. Only 105 of those observations carried a valid recommendation, a valid recommendation coverage rate of 20.11%. That gap between being mentioned and being recommended is the central finding of this report.

The decline is the sharpest in the category. Cetaphil's valid recommendation coverage fell 11.9 percentage points from 32.0% in July 2026 to 20.1% in September 2026, moving down in each of the two months and beyond normal month-to-month variation. Valid recommendation count dropped from 178 observations in July to 105 in September. Raw mention presence fell from 36.6% to 26.1% over the same period. The brand lost presence and recommendation credit together.

Placement quality is the deeper problem. Cetaphil's top-three recommendation rate fell from 9.9% in July to 5.2% in September, and its rank-one rate fell from 2.0% to 0.0%, meaning no September observation placed Cetaphil first among valid recommendations. The brand is present in roughly one in four AI answers but almost never leads the shortlist.

Sentiment framing remains positive. Cetaphil recorded 129 positive mentions, 7 neutral mentions, and 0 negative mentions, producing a net sentiment score of 0.9485. The problem is not how AI systems describe Cetaphil. The problem is how often they choose it.

The strongest platform signal for Cetaphil is Perplexity, where the brand recorded a positive visibility rate of 33.33% and a valid recommendation coverage of 19.70%. The weakest platform signal is Gemini, where Cetaphil recorded a valid recommendation coverage of 11.11% and no rank-one placements. The clearest platform gap is AI Mode, where Cetaphil's valid recommendation coverage of 25.98% trails the category leader by more than 60 percentage points.

The gap against the category leader widened from 48.8 percentage points in July to 58.2 percentage points in September. That widening reflects Cetaphil's decline more than any gain by the leader. The brand has fallen out of the cluster of five brands above 60% valid recommendation coverage and now sits closer to the lower tier of the category.

What Cetaphil Is Winning

Questions This Section Answers

• Where does Cetaphil still perform well in AI sunscreen recommendations?

Cetaphil's wins in this benchmark are narrow but real.

The brand maintains a positive framing profile. With 129 positive mentions against 7 neutral and 0 negative, Cetaphil's net sentiment score of 0.9485 is among the higher scores in the tracked set. AI systems describe Cetaphil favorably when they mention it.

Cetaphil retains a measurable presence in the consideration cluster. The brand appeared in 136 of 522 qualified observations, which places it ahead of Sun Bum, Vichy, and Kopari Beauty on raw mention presence. It is not invisible.

Perplexity shows the strongest relative signal. Cetaphil's positive visibility rate on Perplexity reached 33.33%, the highest across all six tracked platforms for the brand, and its valid recommendation coverage of 19.70% on that platform is close to its overall rate. This suggests Perplexity surfaces Cetaphil in a recommendation context more consistently than other surfaces.

These wins are modest. The brand has no rank-one placements, no top-three rate above 6%, and no platform where it leads the category. The evidence suggests Cetaphil is a recognized name in AI answers but not a preferred recommendation.

Where Cetaphil Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why is Cetaphil mentioned in AI sunscreen answers but left out of the recommendation shortlist?
• Which platforms and placements show the largest gaps for Cetaphil?

Cetaphil's clearest gap is recommendation conversion. The brand appeared in 26.05% of qualified observations but received a valid recommendation in only 20.11%. That 5.94 percentage point gap represents observations where AI systems mentioned Cetaphil without including it in the recommendation shortlist. In a category where the top two brands convert presence to recommendation at rates above 78%, Cetaphil's conversion rate of roughly 77% of its own presence is materially weaker.

The second gap is placement. Cetaphil's top-three rate of 5.2% means the brand appears in a top-three recommendation position in roughly one in twenty qualified observations. Its rank-one rate of 0.0% means it never leads. By comparison, EltaMD holds a top-three rate of 53.64% and a rank-one rate of 30.65%. La Roche-Posay holds a top-three rate of 51.72% and a rank-one rate of 15.52%. The gap between Cetaphil and the category leaders is not a matter of degree. It is a matter of whether Cetaphil enters the shortlist at all.

The third gap is platform coverage. Cetaphil's valid recommendation coverage varies significantly across platforms. On Perplexity, the brand reaches 19.70%. On ChatGPT, it reaches 19.72%. On Copilot, it reaches 14.71%. On Gemini, it falls to 11.11%. On AI Overviews, it reaches 22.05%. On AI Mode, it reaches 25.98%. The brand has no platform where it exceeds 26% valid recommendation coverage, while the category leader exceeds 77% on multiple platforms.

The fourth gap is competitive displacement. The benchmark shows that Cetaphil's decline from 32.0% to 20.1% valid recommendation coverage was not matched by a corresponding decline in category-level recommendation activity. The recommendation-shaped answer share fell only 6.1 percentage points across the category, from 75.0% to 69.0%. Cetaphil's decline of 11.9 percentage points is nearly double the category-level contraction. The evidence suggests other brands captured recommendations that Cetaphil lost.

The fifth gap is the absence of pricing and comparison coverage. The public benchmark recorded zero qualified observations for Pricing & Value or Multi-Brand Comparison queries in either July or September 2026. This means the benchmark cannot show how Cetaphil performs when AI systems are asked to compare brands head-to-head or discuss value. Those commercial questions require dedicated prompt sets beyond the current discovery scope.

Biggest Opportunity

Cetaphil's biggest opportunity is converting its remaining brand presence into shortlist placement in the consideration cluster. The brand still appears in roughly one in four AI answers about sunscreen. The problem is that it rarely appears in the top three and never appears first. The path from reference to recommendation runs through the prompt, page, and citation layers that shape how AI systems construct shortlists.

The specific opportunity is to identify which question types and surfaces still surface Cetaphil and determine what evidence those answers draw on. If AI systems mention Cetaphil but recommend other brands, the gap is likely in how the brand's attributes, use cases, and supporting sources are represented in the public evidence layer. Closing that gap requires targeted work on the owned answer layer and the citation architecture that AI systems retrieve from.

Competitive Landscape

Questions This Section Answers

• How does Cetaphil's top-three and rank-one placement compare with EltaMD, La Roche-Posay, and other sunscreen brands?

EltaMD and La Roche-Posay hold the strongest recommendation-stage positions in the sunscreen category, with EltaMD leading on top-three and rank-one placement and La Roche-Posay leading on overall valid recommendation coverage. Cetaphil sits in the lower tier of the tracked set, with recommendation rates well below the category leaders and no rank-one placements in September 2026.

Average recommended rank covers rank-eligible recommendations only.

Cetaphil's position in the table shows a brand with moderate presence but weak placement. Its top-three rate of 5.17% places it sixth of nine, and its rank-one rate of 0.00% places it in a group with Vichy and Kopari Beauty, both of which have far lower overall presence. The brand's sentiment score of 0.9485 is competitive with the category leaders, which indicates that the issue is not how AI systems describe Cetaphil but how often they select it.

Prompt Evidence

Questions This Section Answers

• Which AI sunscreen prompts and surfaces still produce valid recommendations for Cetaphil?

ChatGPT / Best Sunscreen Brands Discovery & Evaluation Prompt: "Which sunscreen is best for acne-prone skin?" Result: Cetaphil received a valid recommendation in 19.72% of ChatGPT observations, with no rank-one placements.

Perplexity / Best Sunscreen Brands Discovery & Evaluation Prompt: "What is the best mineral sunscreen for rosacea?" Result: Cetaphil recorded its highest positive visibility rate on Perplexity at 33.33%, though valid recommendation coverage remained at 19.70%.

AI Mode / Best Sunscreen Brands Discovery & Evaluation Prompt: "best sunscreen" Result: Cetaphil appeared in 27.56% of AI Mode observations but received a valid recommendation in only 25.98%, with no rank-one placements.

Gemini / Best Sunscreen Brands Discovery & Evaluation Prompt: "sunscreen for face" Result: Cetaphil recorded its weakest platform signal on Gemini, with valid recommendation coverage of 11.11% and no top-three placements above 3.17%.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompts, surfaces, and competitor displacements behind Cetaphil's 11.9-point coverage decline, identifying which question types and platforms reduced the brand's presence and which brands captured the recommendations Cetaphil lost.

Phase 2: Recommendation Readiness Plan Define the attribute, use-case, and evidence gaps that prevent Cetaphil from entering top-three placements, prioritizing the acne-prone, sensitive-skin, and dermatologist-recommended prompt families where the brand has existing equity.

Phase 3: Owned Answer Layer Buildout Strengthen the pages, product descriptions, and structured content that AI systems retrieve when constructing sunscreen shortlists, ensuring Cetaphil's differentiators are represented in extractable, citation-ready formats.

Phase 4: Citation / Authority Layer Development Develop the public evidence layer that supports Cetaphil's recommendation eligibility, including source types, referring domains, and third-party references that AI systems appear to synthesize from.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Cetaphil's presence, valid recommendation coverage, top-three rate, rank-one rate, and sentiment across all six platforms on a monthly basis, with competitor displacement monitoring to detect shifts early.

Why This Matters

Questions This Section Answers

• What is the difference between being mentioned and being recommended for Cetaphil in AI sunscreen answers?

AI presence alone is not enough. Cetaphil appears in roughly one in four AI-generated sunscreen answers, but it is recommended in fewer than one in five and never leads the shortlist. In a category where buyers increasingly form their consideration set through AI-led discovery, the difference between being mentioned and being recommended is the difference between being considered and being chosen.

The next move is targeted correction of the prompt, page, and citation layers that shape how AI systems construct sunscreen recommendations. The benchmark shows where Cetaphil is losing. A company-level analysis shows why, and what to fix first.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

Cetaphil's sentiment score for September 2026 is 0.9485, calculated from 129 positive mentions, 7 neutral mentions, and 0 negative mentions across 136 total mentions.

This score matters because unclassified mention counts are misleading. A brand that appears frequently but is described cautiously or as a comparison anchor is not in the same position as a brand that appears frequently and is recommended positively. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal.

Counting all mentions as wins is bad measurement. Cetaphil's high sentiment score shows that AI systems describe the brand favorably when they mention it. But sentiment alone does not explain why the brand's valid recommendation coverage fell 11.9 percentage points while its sentiment remained stable. Classified sentiment is required before interpreting AI visibility, and it must be read alongside recommendation coverage and placement metrics, not in isolation.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Cetaphil's AI recommendation performance in the Sunscreen Brands category for September 2026. It is not a client implementation case study.
2. The reporting window is September 2026, with month-over-month comparisons to July 2026 and August 2026 where available.
3. Six AI and search surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.
4. The September 2026 benchmark drew on 800 source prompt-surface observations across 667 unique questions. Of those, 540 were relevant to the category and 260 were irrelevant, leaving 522 qualified observations used for brand-level metrics.
5. The competitor universe includes nine tracked brands: Cetaphil, CeraVe, EltaMD, Kopari Beauty, La Roche-Posay, Neutrogena, Sun Bum, Supergoop, and Vichy.
6. All 522 qualified observations in September 2026 fell into the Brand Recommendation buyer-intent cluster, which covers discovery and consideration queries. No qualified observations were recorded for Pricing & Value or Multi-Brand Comparison queries.
7. Stage 0 extraction retained the query, AI surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources.
8. A mention is counted when a tracked brand appears in a qualified AI observation, regardless of whether the brand is recommended.
9. A valid recommendation is counted when a tracked brand receives a positive recommendation with a rank position of 1 through 10. Neutral, cautionary, comparison-anchor, and listed-only mentions are not counted as valid recommendations.
10. Brand-level percentages use the 522 qualified observations as the public denominator, not the 800 raw prompt-surface collections.
11. The public benchmark does not measure market share, sales attribution, organic-search ranking performance, social media mention volume, private or sponsored AI channels, or causality from a metric movement alone.
12. Unique prompt count for the public version is 667. The benchmark does not expose the full prompt-level dataset in the public report.

See How AI Is Recommending Your Brand

The public benchmark shows where Cetaphil is winning and losing in AI-generated sunscreen recommendations. A company-level AI visibility audit maps the specific prompts, surfaces, competitors, and evidence sources behind those results, turning the category standings into a prioritized action plan for improving recommendation coverage and shortlist placement.